NuVasive, Inc. Provides Revenue Guidance for the Fourth Quarter and the Full Year Ended December 31, 2013; Revenue Guidance for the Year 2014
The company anticipates full year 2013 revenue will approximate $683 million. The revenue results compare to previously issued guidance of approximately $670 million in revenue for the full year 2013. The company also anticipates that full year 2013 non-GAAP operating margin will exceed previously issued guidance of approximately 14.5%.
The company expects 2014 revenue to approximate $725 million, in line with the mid-single digit revenue growth guidance that the company communicated previously. Revenue guidance for 2014 contemplates continued market share gains within a stabilizing domestic spine market.